In vitro genotoxic perspective of Tamiflu
Identifieur interne : 000731 ( Ncbi/Merge ); précédent : 000730; suivant : 000732In vitro genotoxic perspective of Tamiflu
Auteurs : Hasan Basri Ila [Turquie] ; Ahmet Ilhan [Turquie]Source :
- Cytotechnology [ 0920-9069 ] ; 2012.
Abstract
The aim of this study was to investigate the genotoxic and/or cytotoxic effects of Tamiflu, commercial form of the oseltamivir antiviral and most frequently prescribed for the treatment of influenza infections, on cultured human peripheral lymphocytes by using sister chromatid exchange (SCE), chromosomal aberration (CA), and cytokinesis-blocked micronucleus (CBMN) assays. Cells were treated with 0.5, 1, 2 μg/mL oseltamivir, the Tamiflu capsule ingredient, for 24 or 48 h in the absence or presence of an exogenous metabolic activation system (S9 mix). The test chemical did not demonstrate any genotoxic effect dose-dependently but it showed a weak cytotoxicity on cells in this study. On the other hand, some concentrations of Tamiflu (2 μg/mL without S9 mix for 48 h and 1 μg/mL with S9 mix) induced SCE and also decreased significantly the proliferation index (PI) (48 h period) and the nuclear division index (NDI) (24 h period) (
Url:
DOI: 10.1007/s10616-011-9422-1
PubMed: 22252233
PubMed Central: 3397114
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000127
- to stream Pmc, to step Curation: 000127
- to stream Pmc, to step Checkpoint: 000716
Links to Exploration step
PMC:3397114Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">In vitro genotoxic perspective of Tamiflu</title>
<author><name sortKey="Ila, Hasan Basri" sort="Ila, Hasan Basri" uniqKey="Ila H" first="Hasan Basri" last="Ila">Hasan Basri Ila</name>
<affiliation wicri:level="1"><nlm:aff id="Aff1">Department of Biology, Faculty of Science and Letters, Cukurova University, 01330 Adana, Turkey</nlm:aff>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Biology, Faculty of Science and Letters, Cukurova University, 01330 Adana</wicri:regionArea>
<wicri:noRegion>01330 Adana</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ilhan, Ahmet" sort="Ilhan, Ahmet" uniqKey="Ilhan A" first="Ahmet" last="Ilhan">Ahmet Ilhan</name>
<affiliation wicri:level="1"><nlm:aff id="Aff1">Department of Biology, Faculty of Science and Letters, Cukurova University, 01330 Adana, Turkey</nlm:aff>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Biology, Faculty of Science and Letters, Cukurova University, 01330 Adana</wicri:regionArea>
<wicri:noRegion>01330 Adana</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">22252233</idno>
<idno type="pmc">3397114</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397114</idno>
<idno type="RBID">PMC:3397114</idno>
<idno type="doi">10.1007/s10616-011-9422-1</idno>
<date when="2012">2012</date>
<idno type="wicri:Area/Pmc/Corpus">000127</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000127</idno>
<idno type="wicri:Area/Pmc/Curation">000127</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000127</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000716</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000716</idno>
<idno type="wicri:Area/Ncbi/Merge">000731</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">In vitro genotoxic perspective of Tamiflu</title>
<author><name sortKey="Ila, Hasan Basri" sort="Ila, Hasan Basri" uniqKey="Ila H" first="Hasan Basri" last="Ila">Hasan Basri Ila</name>
<affiliation wicri:level="1"><nlm:aff id="Aff1">Department of Biology, Faculty of Science and Letters, Cukurova University, 01330 Adana, Turkey</nlm:aff>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Biology, Faculty of Science and Letters, Cukurova University, 01330 Adana</wicri:regionArea>
<wicri:noRegion>01330 Adana</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ilhan, Ahmet" sort="Ilhan, Ahmet" uniqKey="Ilhan A" first="Ahmet" last="Ilhan">Ahmet Ilhan</name>
<affiliation wicri:level="1"><nlm:aff id="Aff1">Department of Biology, Faculty of Science and Letters, Cukurova University, 01330 Adana, Turkey</nlm:aff>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Biology, Faculty of Science and Letters, Cukurova University, 01330 Adana</wicri:regionArea>
<wicri:noRegion>01330 Adana</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Cytotechnology</title>
<idno type="ISSN">0920-9069</idno>
<idno type="eISSN">1573-0778</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>The aim of this study was to investigate the genotoxic and/or cytotoxic effects of Tamiflu, commercial form of the oseltamivir antiviral and most frequently prescribed for the treatment of influenza infections, on cultured human peripheral lymphocytes by using sister chromatid exchange (SCE), chromosomal aberration (CA), and cytokinesis-blocked micronucleus (CBMN) assays. Cells were treated with 0.5, 1, 2 μg/mL oseltamivir, the Tamiflu capsule ingredient, for 24 or 48 h in the absence or presence of an exogenous metabolic activation system (S9 mix). The test chemical did not demonstrate any genotoxic effect dose-dependently but it showed a weak cytotoxicity on cells in this study. On the other hand, some concentrations of Tamiflu (2 μg/mL without S9 mix for 48 h and 1 μg/mL with S9 mix) induced SCE and also decreased significantly the proliferation index (PI) (48 h period) and the nuclear division index (NDI) (24 h period) (<italic>P</italic>
< 0.05) in the absence of S9 mix. Considering the results, Tamiflu did not induce significant increases of CA or micronucleated cells in vitro in cultured peripheral blood lymphocytes under the treatment conditions used but weak SCE induction was observed. On the other hand, the weak cytotoxic effects observed disappeared in the cultures treated in presence of the S9 mix.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Cytotechnology</journal-id>
<journal-id journal-id-type="iso-abbrev">Cytotechnology</journal-id>
<journal-title-group><journal-title>Cytotechnology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0920-9069</issn>
<issn pub-type="epub">1573-0778</issn>
<publisher><publisher-name>Springer Netherlands</publisher-name>
<publisher-loc>Dordrecht</publisher-loc>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">22252233</article-id>
<article-id pub-id-type="pmc">3397114</article-id>
<article-id pub-id-type="publisher-id">9422</article-id>
<article-id pub-id-type="doi">10.1007/s10616-011-9422-1</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group><article-title>In vitro genotoxic perspective of Tamiflu</article-title>
</title-group>
<contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Ila</surname>
<given-names>Hasan Basri</given-names>
</name>
<address><phone>+90-3223386084</phone>
<fax>+90-3223386070</fax>
<email>milenium@cu.edu.tr</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Ilhan</surname>
<given-names>Ahmet</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<aff id="Aff1">Department of Biology, Faculty of Science and Letters, Cukurova University, 01330 Adana, Turkey</aff>
</contrib-group>
<pub-date pub-type="epub"><day>18</day>
<month>1</month>
<year>2012</year>
</pub-date>
<pub-date pub-type="ppub"><month>8</month>
<year>2012</year>
</pub-date>
<volume>64</volume>
<issue>4</issue>
<fpage>443</fpage>
<lpage>449</lpage>
<history><date date-type="received"><day>15</day>
<month>3</month>
<year>2011</year>
</date>
<date date-type="accepted"><day>20</day>
<month>12</month>
<year>2011</year>
</date>
</history>
<permissions><copyright-statement>© Springer Science+Business Media B.V. 2012</copyright-statement>
</permissions>
<abstract id="Abs1"><p>The aim of this study was to investigate the genotoxic and/or cytotoxic effects of Tamiflu, commercial form of the oseltamivir antiviral and most frequently prescribed for the treatment of influenza infections, on cultured human peripheral lymphocytes by using sister chromatid exchange (SCE), chromosomal aberration (CA), and cytokinesis-blocked micronucleus (CBMN) assays. Cells were treated with 0.5, 1, 2 μg/mL oseltamivir, the Tamiflu capsule ingredient, for 24 or 48 h in the absence or presence of an exogenous metabolic activation system (S9 mix). The test chemical did not demonstrate any genotoxic effect dose-dependently but it showed a weak cytotoxicity on cells in this study. On the other hand, some concentrations of Tamiflu (2 μg/mL without S9 mix for 48 h and 1 μg/mL with S9 mix) induced SCE and also decreased significantly the proliferation index (PI) (48 h period) and the nuclear division index (NDI) (24 h period) (<italic>P</italic>
< 0.05) in the absence of S9 mix. Considering the results, Tamiflu did not induce significant increases of CA or micronucleated cells in vitro in cultured peripheral blood lymphocytes under the treatment conditions used but weak SCE induction was observed. On the other hand, the weak cytotoxic effects observed disappeared in the cultures treated in presence of the S9 mix.</p>
</abstract>
<kwd-group xml:lang="en"><title>Keywords</title>
<kwd>Tamiflu</kwd>
<kwd>Oseltamivir</kwd>
<kwd>In vitro human lymphocytes</kwd>
<kwd>Sister chromatid exchange</kwd>
<kwd>Micronuclei</kwd>
<kwd>Cytotoxicity</kwd>
</kwd-group>
<custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name>
<meta-value>© Springer Science+Business Media B.V. 2012</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</pmc>
<affiliations><list><country><li>Turquie</li>
</country>
</list>
<tree><country name="Turquie"><noRegion><name sortKey="Ila, Hasan Basri" sort="Ila, Hasan Basri" uniqKey="Ila H" first="Hasan Basri" last="Ila">Hasan Basri Ila</name>
</noRegion>
<name sortKey="Ilhan, Ahmet" sort="Ilhan, Ahmet" uniqKey="Ilhan A" first="Ahmet" last="Ilhan">Ahmet Ilhan</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000731 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000731 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= H2N2V1 |flux= Ncbi |étape= Merge |type= RBID |clé= PMC:3397114 |texte= In vitro genotoxic perspective of Tamiflu }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:22252233" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a H2N2V1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |